- Home
- CHRW vs NBIX Comparison
CHRW vs NBIX Comparison
Compare CHRW & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRW
- NBIX
- Stock Information
- Founded
- CHRW 1905
- NBIX 1992
- Country
- CHRW United States
- NBIX United States
- Employees
- CHRW N/A
- NBIX N/A
- Industry
- CHRW Oil Refining/Marketing
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CHRW Consumer Discretionary
- NBIX Health Care
- Exchange
- CHRW Nasdaq
- NBIX Nasdaq
- Market Cap
- CHRW 14.8B
- NBIX 14.4B
- IPO Year
- CHRW 1997
- NBIX 1996
- Fundamental
- Price
- CHRW $149.33
- NBIX $150.87
- Analyst Decision
- CHRW Buy
- NBIX Strong Buy
- Analyst Count
- CHRW 22
- NBIX 18
- Target Price
- CHRW $137.86
- NBIX $172.06
- AVG Volume (30 Days)
- CHRW 1.7M
- NBIX 1.0M
- Earning Date
- CHRW 10-29-2025
- NBIX 10-28-2025
- Dividend Yield
- CHRW 1.66%
- NBIX N/A
- EPS Growth
- CHRW 70.68
- NBIX 12.44
- EPS
- CHRW 4.94
- NBIX 4.19
- Revenue
- CHRW $16,504,785,000.00
- NBIX $2,682,700,000.00
- Revenue This Year
- CHRW N/A
- NBIX $23.68
- Revenue Next Year
- CHRW $3.07
- NBIX $18.02
- P/E Ratio
- CHRW $30.32
- NBIX $35.78
- Revenue Growth
- CHRW N/A
- NBIX 19.61
- 52 Week Low
- CHRW $84.68
- NBIX $84.23
- 52 Week High
- CHRW $158.70
- NBIX $157.67
- Technical
- Relative Strength Index (RSI)
- CHRW 67.43
- NBIX 59.16
- Support Level
- CHRW $150.32
- NBIX $133.62
- Resistance Level
- CHRW $154.68
- NBIX $157.67
- Average True Range (ATR)
- CHRW 3.73
- NBIX 4.58
- MACD
- CHRW 1.97
- NBIX 0.98
- Stochastic Oscillator
- CHRW 71.89
- NBIX 67.98
About CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 60% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (30%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of transportation management services and a legacy produce-sourcing operation.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.